This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Gelteq centers its technology on a proprietary, customizable gel platform designed for precise drugdelivery, supporting prescription drugs, nutraceuticals, pet care and sports supplements. Priced at $4.0
A new intracellular drugdelivery centre will be established in the UK to support potential ribonucleic acid (RNA) vaccines and therapeutics , as well as the development of innovative drugdelivery technologies. Another key focus area will be the creation of a framework to develop advanced nano-delivery systems.
In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Key innovation: Leading companies in nanoparticles for drugdelivery. Bristol-Myers Squibb is the leading patent filer in nanoparticles for drugdelivery.
Enhance medication dosing accuracy with Sanofi's patented optical decoding system for drugdelivery devices. Improve efficiency and precision in dispensing with this innovative technology.
On May 5, a panel of experienced industry experts will discuss recent developments during Innovations in DrugDelivery, a free one-hour industry webinar.
Paris, will open in May (18-19) with connectivity, sustainability and user experience identified as the key trends in 2022 influencing innovation across pharmaceutical packaging and drugdelivery. Pharmapack Europe will be held as Smart Event to enhance the benefits for global attendees, providing a hybrid experience that extends the.
The successful launch of mRNA vaccines during the Covid-19 pandemic has not only spurred mRNA-related research across interdisciplinary groups, but also further validated the use of lipid nanoparticles as delivery approaches.
Patient feedback is driving innovation in next-generation drugdelivery devices, improving patient adherence and experience. Learn how these advancements are shaping the future of healthcare.
FDA recently released a much-anticipated draft guidance to address these frequent questions: Essential DrugDelivery Outputs for Devices Intended to Deliver Drugs and Biological Products. Drugdelivery includes successful product preparation and the initiation, progression, and completion of dose delivery.
The post Maculus Therapeutix welcomes Privity FZ LLE and Prepares Capital Raise for Novel DrugDelivery Platform appeared first on Pharma Mirror Magazine. Maculus achieved the breakthrough using a patented novel tunable biodegradable proprietary product, MacuBloc. Capable of delivering any FDA approved.
Additionally, a collaboration with NurExone is creating an intranasal delivery system for exosome-based therapies targeting spinal cord injuries, with potential expansion into other neurological uses. Polyrizon’s focus on intranasal protection aligns with a rapidly expanding market in drugdelivery innovation.
Clinical-stage drugdelivery and development company DelSiTech has made the biggest single financing round in its history with the successful completion of a â10 million deal.
Interest in the pulmonary route has also grown in recent years because delivering the drugs through the lungs allows direct systemic delivery and bypasses the first pass metabolism. Why is pulmonary drugdelivery a complex challenge? How can we accomplish drugdelivery to the lungs in nonclinical studies?
Drugdelivery technology is aimed at helping people with spinal cord and other nervous system disorders Credit: KiBum Lee, Letao Yang and Brian M. The system, […].
A REVIEW OF MAGNETIC NANOPARTICLES IN TARGETED DRUGDELIVERY admin Mon, 05/29/2023 - 15:04 About Authors CHETNA MODI 1 *, VINIT MODI 2 , SHWETA RAY 2 , PIYUSH NARIYA 2 , VARSHA GADHVI 2 1 Professor, Department of Pharmaceutics, Anand Pharmacy College, Anand, Gujarat, India. chetnamodi306@gmail.com
The biotech’s transition from drugdelivery specialist to maker of novel medicines led to competing neuroscience and oncology divisions. The latter will soon become a separate company.
Astria Therapeutics has selected Ypsomed’s Ypsomate autoinjector as its partner for the administration of STAR-0215 for the treatment of hereditary angioedema (HAE).
at Northwestern University—has developed novel technology with the potential to change the future of drugdelivery. A team of scientists—led by Yamin Zhang, Ph.D., and Colin Franz, MD, Ph.D., at Shirley Ryan AbilityLab and John Rogers, Ph.D.,
Antares Pharma's auto-injector technology is of particular interest to Halozyme, which believes that the various markets to which it could be applied represent billions of dollars in potential sales.
Learn about the groundbreaking method for administering the drug conjugate and its potential impact on treating AMD, DR, RVO, and more. Discover Ascendis Pharma's innovative patent for hydrogel prodrug compositions using cross-linked hyaluronic acid to treat ocular conditions.
Amazon Pharmacy launched a pair of TV spots last month to showcase the ease of its drugdelivery service for consumers. In 2023, it introduced RxPass , a prescription drug program that offers common drugs for a flat fee of $5. According to Statista , the global online pharmacy market is predicted to hit $82.42
A team of scientists from the universities of Glasgow and Tel Aviv has developed a groundbreaking method to transform the brain parasite Toxoplasma gondii into a potential vehicle for delivering therapeutic treatments directly to brain cells.
Genentech’s ocular implant drugdelivery system for treatment of macular degeneration has received approval from the US Food and Drug Administration (FDA). Susvimo delivers ranibizumab via a port delivery system into a surgically placed implant in the eye, allowing for continuous delivery of the drug.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content